HEADER SERINE PROTEASE INHIBITOR 23-NOV-97 1AZX TITLE ANTITHROMBIN/PENTASACCHARIDE COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTITHROMBIN; COMPND 3 CHAIN: I, L SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: PLASMA; SOURCE 6 TISSUE: PLASMA; SOURCE 7 OTHER_DETAILS: PENTASACCHARIDE WAS CHEMICALLY SYNTHESIZED KEYWDS SERINE PROTEASE INHIBITOR, SERPIN, ANTITHROMBIN, ANTICOAGULANT KEYWDS 2 ACTIVATION BY HEPARIN EXPDTA X-RAY DIFFRACTION AUTHOR L.JIN,J.P.ABRAHAMS,R.SKINNER,M.PETITOU,R.N.PIKE,R.W.CARRELL REVDAT 6 30-OCT-24 1AZX 1 HETSYN REVDAT 5 29-JUL-20 1AZX 1 COMPND REMARK HET HETNAM REVDAT 5 2 1 FORMUL LINK SITE ATOM REVDAT 4 13-JUL-11 1AZX 1 VERSN REVDAT 3 24-FEB-09 1AZX 1 VERSN REVDAT 2 01-APR-03 1AZX 1 JRNL REVDAT 1 13-JAN-99 1AZX 0 JRNL AUTH L.JIN,J.P.ABRAHAMS,R.SKINNER,M.PETITOU,R.N.PIKE,R.W.CARRELL JRNL TITL THE ANTICOAGULANT ACTIVATION OF ANTITHROMBIN BY HEPARIN. JRNL REF PROC.NATL.ACAD.SCI.USA V. 94 14683 1997 JRNL REFN ISSN 0027-8424 JRNL PMID 9405673 JRNL DOI 10.1073/PNAS.94.26.14683 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT 5D REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 3 NUMBER OF REFLECTIONS : 24096 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT : 851 REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6639 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 242 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : NULL ; NULL ; NULL REMARK 3 BOND ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES (A) : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : NULL ; NULL ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : NULL REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1AZX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000171460. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : AUG-96 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX9.6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.87 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM, CCP4 REMARK 200 DATA SCALING SOFTWARE : CCP4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 60010 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : 0.12400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.87 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 43.48500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: I, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 HUMAN ANTITHROMBIN IS A PLASMA GLYCOPROTEIN, WITH 432 REMARK 400 AMINO ACID RESIDUES AND FOUR GLYCOSYLATION SITES: ASN REMARK 400 96, ASN 135, ASN 155 AND ASN 192. THERE ARE TWO REMARK 400 ANTITHROMBIN MOLECULES IN THE ASYMMETRIC UNIT: I AND L, REMARK 400 BOTH ARE COMPLEXED BY THE HEPARIN PENTASACCHARIDE. FOR I REMARK 400 MOLECULE, RESIDUES 1, 26-38, AND 432 WERE NOT BUILT REMARK 400 BECAUSE OF POOR ELECTRON DENSITY MAPS. FOR L MOLECULE, REMARK 400 RESIDUES 1-4, 26-38 AND 432 WERE NOT BUILT. THREE NAG REMARK 400 MOLECULES, ATTACHED TO ASN 155 OF I MOLECULE, AND ASN 155 REMARK 400 AND ASN 192 OF L MOLECULE, RESPECTIVELY, WERE BUILT INTO REMARK 400 CLEAR DENSITY. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS I 1 REMARK 465 PRO I 26 REMARK 465 GLU I 27 REMARK 465 LYS I 28 REMARK 465 LYS I 29 REMARK 465 ALA I 30 REMARK 465 THR I 31 REMARK 465 GLU I 32 REMARK 465 ASP I 33 REMARK 465 GLU I 34 REMARK 465 GLY I 35 REMARK 465 SER I 36 REMARK 465 GLU I 37 REMARK 465 GLN I 38 REMARK 465 LYS I 432 REMARK 465 HIS L 1 REMARK 465 GLY L 2 REMARK 465 SER L 3 REMARK 465 PRO L 4 REMARK 465 PRO L 26 REMARK 465 GLU L 27 REMARK 465 LYS L 28 REMARK 465 LYS L 29 REMARK 465 ALA L 30 REMARK 465 THR L 31 REMARK 465 GLU L 32 REMARK 465 ASP L 33 REMARK 465 GLU L 34 REMARK 465 GLY L 35 REMARK 465 SER L 36 REMARK 465 GLU L 37 REMARK 465 GLN L 38 REMARK 465 LYS L 432 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CG ASN I 155 C1 NAG I 501 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO L 288 C - N - CA ANGL. DEV. = 9.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO I 4 -119.61 -102.32 REMARK 500 VAL I 5 -60.28 68.17 REMARK 500 ASP I 6 -76.40 -35.67 REMARK 500 MET I 17 61.99 -151.09 REMARK 500 ILE I 40 139.73 170.77 REMARK 500 ASN I 96 -133.45 49.08 REMARK 500 SER I 137 -14.89 -152.88 REMARK 500 ALA I 143 81.99 -174.52 REMARK 500 SER I 151 42.14 -73.35 REMARK 500 ASN I 155 109.47 -58.48 REMARK 500 ASN I 178 62.69 -109.58 REMARK 500 THR I 199 -122.16 -99.59 REMARK 500 ASP I 200 81.03 -54.82 REMARK 500 GLU I 205 -10.43 73.51 REMARK 500 LYS I 222 106.86 -160.94 REMARK 500 GLU I 232 6.84 -64.47 REMARK 500 ASP I 277 -15.92 62.87 REMARK 500 LYS I 332 -73.71 -40.73 REMARK 500 LEU I 340 83.28 -65.27 REMARK 500 VAL I 341 -63.92 -98.96 REMARK 500 ARG I 359 -179.33 43.08 REMARK 500 ASP I 361 -47.94 -162.90 REMARK 500 ASN I 376 -157.34 -135.24 REMARK 500 GLU I 378 -1.08 -143.95 REMARK 500 SER I 380 108.48 -54.07 REMARK 500 ALA I 382 -164.76 -105.22 REMARK 500 ALA I 383 100.97 -48.09 REMARK 500 ASN I 398 58.21 -114.09 REMARK 500 PRO I 407 139.98 -36.76 REMARK 500 ASN I 428 108.02 -168.08 REMARK 500 SER L 69 30.02 -96.08 REMARK 500 ASN L 96 -143.94 65.33 REMARK 500 THR L 110 43.97 -97.93 REMARK 500 GLN L 118 33.57 -143.26 REMARK 500 ASN L 135 67.13 67.28 REMARK 500 ARG L 145 147.60 -170.26 REMARK 500 VAL L 263 -158.84 -100.65 REMARK 500 ASP L 277 -2.25 63.32 REMARK 500 PRO L 288 -28.03 -26.76 REMARK 500 VAL L 341 -64.21 -105.84 REMARK 500 ILE L 354 -65.83 -104.62 REMARK 500 GLU L 357 10.09 -60.25 REMARK 500 ASP L 360 46.38 -101.66 REMARK 500 ALA L 391 113.17 67.96 REMARK 500 PRO L 397 178.28 -54.52 REMARK 500 ALA L 404 -109.69 -71.34 REMARK 500 REMARK 500 REMARK: NULL DBREF 1AZX I 1 432 UNP P01008 ANT3_HUMAN 33 464 DBREF 1AZX L 1 432 UNP P01008 ANT3_HUMAN 33 464 SEQRES 1 I 432 HIS GLY SER PRO VAL ASP ILE CYS THR ALA LYS PRO ARG SEQRES 2 I 432 ASP ILE PRO MET ASN PRO MET CYS ILE TYR ARG SER PRO SEQRES 3 I 432 GLU LYS LYS ALA THR GLU ASP GLU GLY SER GLU GLN LYS SEQRES 4 I 432 ILE PRO GLU ALA THR ASN ARG ARG VAL TRP GLU LEU SER SEQRES 5 I 432 LYS ALA ASN SER ARG PHE ALA THR THR PHE TYR GLN HIS SEQRES 6 I 432 LEU ALA ASP SER LYS ASN ASP ASN ASP ASN ILE PHE LEU SEQRES 7 I 432 SER PRO LEU SER ILE SER THR ALA PHE ALA MET THR LYS SEQRES 8 I 432 LEU GLY ALA CYS ASN ASP THR LEU GLN GLN LEU MET GLU SEQRES 9 I 432 VAL PHE LYS PHE ASP THR ILE SER GLU LYS THR SER ASP SEQRES 10 I 432 GLN ILE HIS PHE PHE PHE ALA LYS LEU ASN CYS ARG LEU SEQRES 11 I 432 TYR ARG LYS ALA ASN LYS SER SER LYS LEU VAL SER ALA SEQRES 12 I 432 ASN ARG LEU PHE GLY ASP LYS SER LEU THR PHE ASN GLU SEQRES 13 I 432 THR TYR GLN ASP ILE SER GLU LEU VAL TYR GLY ALA LYS SEQRES 14 I 432 LEU GLN PRO LEU ASP PHE LYS GLU ASN ALA GLU GLN SER SEQRES 15 I 432 ARG ALA ALA ILE ASN LYS TRP VAL SER ASN LYS THR GLU SEQRES 16 I 432 GLY ARG ILE THR ASP VAL ILE PRO SER GLU ALA ILE ASN SEQRES 17 I 432 GLU LEU THR VAL LEU VAL LEU VAL ASN THR ILE TYR PHE SEQRES 18 I 432 LYS GLY LEU TRP LYS SER LYS PHE SER PRO GLU ASN THR SEQRES 19 I 432 ARG LYS GLU LEU PHE TYR LYS ALA ASP GLY GLU SER CYS SEQRES 20 I 432 SER ALA SER MET MET TYR GLN GLU GLY LYS PHE ARG TYR SEQRES 21 I 432 ARG ARG VAL ALA GLU GLY THR GLN VAL LEU GLU LEU PRO SEQRES 22 I 432 PHE LYS GLY ASP ASP ILE THR MET VAL LEU ILE LEU PRO SEQRES 23 I 432 LYS PRO GLU LYS SER LEU ALA LYS VAL GLU LYS GLU LEU SEQRES 24 I 432 THR PRO GLU VAL LEU GLN GLU TRP LEU ASP GLU LEU GLU SEQRES 25 I 432 GLU MET MET LEU VAL VAL HIS MET PRO ARG PHE ARG ILE SEQRES 26 I 432 GLU ASP GLY PHE SER LEU LYS GLU GLN LEU GLN ASP MET SEQRES 27 I 432 GLY LEU VAL ASP LEU PHE SER PRO GLU LYS SER LYS LEU SEQRES 28 I 432 PRO GLY ILE VAL ALA GLU GLY ARG ASP ASP LEU TYR VAL SEQRES 29 I 432 SER ASP ALA PHE HIS LYS ALA PHE LEU GLU VAL ASN GLU SEQRES 30 I 432 GLU GLY SER GLU ALA ALA ALA SER THR ALA VAL VAL ILE SEQRES 31 I 432 ALA GLY ARG SER LEU ASN PRO ASN ARG VAL THR PHE LYS SEQRES 32 I 432 ALA ASN ARG PRO PHE LEU VAL PHE ILE ARG GLU VAL PRO SEQRES 33 I 432 LEU ASN THR ILE ILE PHE MET GLY ARG VAL ALA ASN PRO SEQRES 34 I 432 CYS VAL LYS SEQRES 1 L 432 HIS GLY SER PRO VAL ASP ILE CYS THR ALA LYS PRO ARG SEQRES 2 L 432 ASP ILE PRO MET ASN PRO MET CYS ILE TYR ARG SER PRO SEQRES 3 L 432 GLU LYS LYS ALA THR GLU ASP GLU GLY SER GLU GLN LYS SEQRES 4 L 432 ILE PRO GLU ALA THR ASN ARG ARG VAL TRP GLU LEU SER SEQRES 5 L 432 LYS ALA ASN SER ARG PHE ALA THR THR PHE TYR GLN HIS SEQRES 6 L 432 LEU ALA ASP SER LYS ASN ASP ASN ASP ASN ILE PHE LEU SEQRES 7 L 432 SER PRO LEU SER ILE SER THR ALA PHE ALA MET THR LYS SEQRES 8 L 432 LEU GLY ALA CYS ASN ASP THR LEU GLN GLN LEU MET GLU SEQRES 9 L 432 VAL PHE LYS PHE ASP THR ILE SER GLU LYS THR SER ASP SEQRES 10 L 432 GLN ILE HIS PHE PHE PHE ALA LYS LEU ASN CYS ARG LEU SEQRES 11 L 432 TYR ARG LYS ALA ASN LYS SER SER LYS LEU VAL SER ALA SEQRES 12 L 432 ASN ARG LEU PHE GLY ASP LYS SER LEU THR PHE ASN GLU SEQRES 13 L 432 THR TYR GLN ASP ILE SER GLU LEU VAL TYR GLY ALA LYS SEQRES 14 L 432 LEU GLN PRO LEU ASP PHE LYS GLU ASN ALA GLU GLN SER SEQRES 15 L 432 ARG ALA ALA ILE ASN LYS TRP VAL SER ASN LYS THR GLU SEQRES 16 L 432 GLY ARG ILE THR ASP VAL ILE PRO SER GLU ALA ILE ASN SEQRES 17 L 432 GLU LEU THR VAL LEU VAL LEU VAL ASN THR ILE TYR PHE SEQRES 18 L 432 LYS GLY LEU TRP LYS SER LYS PHE SER PRO GLU ASN THR SEQRES 19 L 432 ARG LYS GLU LEU PHE TYR LYS ALA ASP GLY GLU SER CYS SEQRES 20 L 432 SER ALA SER MET MET TYR GLN GLU GLY LYS PHE ARG TYR SEQRES 21 L 432 ARG ARG VAL ALA GLU GLY THR GLN VAL LEU GLU LEU PRO SEQRES 22 L 432 PHE LYS GLY ASP ASP ILE THR MET VAL LEU ILE LEU PRO SEQRES 23 L 432 LYS PRO GLU LYS SER LEU ALA LYS VAL GLU LYS GLU LEU SEQRES 24 L 432 THR PRO GLU VAL LEU GLN GLU TRP LEU ASP GLU LEU GLU SEQRES 25 L 432 GLU MET MET LEU VAL VAL HIS MET PRO ARG PHE ARG ILE SEQRES 26 L 432 GLU ASP GLY PHE SER LEU LYS GLU GLN LEU GLN ASP MET SEQRES 27 L 432 GLY LEU VAL ASP LEU PHE SER PRO GLU LYS SER LYS LEU SEQRES 28 L 432 PRO GLY ILE VAL ALA GLU GLY ARG ASP ASP LEU TYR VAL SEQRES 29 L 432 SER ASP ALA PHE HIS LYS ALA PHE LEU GLU VAL ASN GLU SEQRES 30 L 432 GLU GLY SER GLU ALA ALA ALA SER THR ALA VAL VAL ILE SEQRES 31 L 432 ALA GLY ARG SER LEU ASN PRO ASN ARG VAL THR PHE LYS SEQRES 32 L 432 ALA ASN ARG PRO PHE LEU VAL PHE ILE ARG GLU VAL PRO SEQRES 33 L 432 LEU ASN THR ILE ILE PHE MET GLY ARG VAL ALA ASN PRO SEQRES 34 L 432 CYS VAL LYS MODRES 1AZX ASN I 155 ASN GLYCOSYLATION SITE MODRES 1AZX ASN L 155 ASN GLYCOSYLATION SITE MODRES 1AZX ASN L 192 ASN GLYCOSYLATION SITE HET Z9L A 1 25 HET Z9K A 2 17 HET GU6 A 3 23 HET GU1 A 4 14 HET Z9H A 5 21 HET Z9L B 1 25 HET Z9K B 2 17 HET GU6 B 3 23 HET GU1 B 4 14 HET Z9H B 5 21 HET NAG I 501 14 HET NAG L 501 14 HET NAG L 502 14 HETNAM Z9L METHYL 2,3,6-TRI-O-SULFO-ALPHA-D-GLUCOPYRANOSIDE HETNAM Z9K 3-O-METHYL-2-O-SULFO-ALPHA-L-IDOPYRANURONIC ACID HETNAM GU6 2,3,6-TRI-O-SULFO-ALPHA-D-GLUCOPYRANOSE HETNAM GU1 2,3-DI-O-METHYL-BETA-D-GLUCOPYRANURONIC ACID HETNAM Z9H 3,4-DI-O-METHYL-2,6-DI-O-SULFO-ALPHA-D-GLUCOPYRANOSE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN GU6 2,3,6-TRI-O-SULFONATO-ALPHA-D-GLUCOPYRANOSE; 2,3,6-TRI- HETSYN 2 GU6 O-SULFO-ALPHA-D-GLUCOSE; 2,3,6-TRI-O-SULFO-D-GLUCOSE; HETSYN 3 GU6 2,3,6-TRI-O-SULFO-GLUCOSE HETSYN GU1 2,3-DI-O-METHYL-BETA-D-GLUCURONIC ACID; 2,3-DI-O- HETSYN 2 GU1 METHYL-D-GLUCURONIC ACID; 2,3-DI-O-METHYL-GLUCURONIC HETSYN 3 GU1 ACID HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 Z9L 2(C7 H14 O15 S3) FORMUL 3 Z9K 2(C7 H12 O10 S) FORMUL 3 GU6 2(C6 H12 O15 S3) FORMUL 3 GU1 2(C8 H14 O7) FORMUL 3 Z9H 2(C8 H16 O12 S2) FORMUL 5 NAG 3(C8 H15 N O6) HELIX 1 A ARG I 46 SER I 69 1 24 HELIX 2 B PRO I 80 GLY I 93 1 14 HELIX 3 C ASP I 97 PHE I 106 1 10 HELIX 4 P GLU I 113 GLN I 118 1 6 HELIX 5 D GLN I 118 LYS I 136 1 19 HELIX 6 E GLU I 156 LEU I 164 1 9 HELIX 7 F ALA I 179 THR I 194 1 16 HELIX 8 G LEU I 292 GLU I 298 1 7 HELIX 9 H PRO I 301 GLU I 310 1 10 HELIX 10 I LYS I 332 MET I 338 1 7 HELIX 11 AA ARG L 46 SER L 69 1 24 HELIX 12 BB PRO L 80 GLY L 93 1 14 HELIX 13 CC ASP L 97 PHE L 106 1 10 HELIX 14 PP GLU L 113 GLN L 118 1 6 HELIX 15 DD GLN L 118 LEU L 130 1 13 HELIX 16 EE GLU L 156 LEU L 164 1 9 HELIX 17 FF ALA L 179 THR L 194 1 16 HELIX 18 GG LEU L 292 GLU L 298 1 7 HELIX 19 HH PRO L 301 GLU L 310 1 10 HELIX 20 II LYS L 332 MET L 338 1 7 SHEET 1 IA 5 LEU I 170 LEU I 173 0 SHEET 2 IA 5 SER I 138 GLY I 148 1 N GLY I 148 O GLN I 171 SHEET 3 IA 5 LEU I 213 GLY I 223 -1 N LYS I 222 O LYS I 139 SHEET 4 IA 5 SER I 365 ASN I 376 1 N ASP I 366 O LEU I 215 SHEET 5 IA 5 ARG I 322 SER I 330 -1 N PHE I 329 O HIS I 369 SHEET 1 IB 6 ASN I 75 SER I 79 0 SHEET 2 IB 6 ASN I 418 VAL I 426 -1 N ARG I 425 O ILE I 76 SHEET 3 IB 6 PHE I 408 VAL I 415 -1 N GLU I 414 O THR I 419 SHEET 4 IB 6 ILE I 279 PRO I 286 -1 N ILE I 284 O LEU I 409 SHEET 5 IB 6 THR I 267 PHE I 274 -1 N LEU I 272 O MET I 281 SHEET 6 IB 6 ARG I 259 VAL I 263 -1 N ARG I 261 O VAL I 269 SHEET 1 IC 4 THR I 234 LYS I 241 0 SHEET 2 IC 4 GLY I 244 GLU I 255 -1 N MET I 251 O ARG I 235 SHEET 3 IC 4 LEU I 316 MET I 320 -1 N MET I 320 O MET I 252 SHEET 4 IC 4 VAL I 400 ALA I 404 1 N PHE I 402 O VAL I 317 SHEET 1 LA 6 LEU L 170 LEU L 173 0 SHEET 2 LA 6 SER L 138 GLY L 148 1 N LEU L 146 O GLN L 171 SHEET 3 LA 6 LEU L 213 GLY L 223 -1 N LYS L 222 O LYS L 139 SHEET 4 LA 6 GLY L 379 ILE L 390 -1 N ILE L 390 O LEU L 213 SHEET 5 LA 6 SER L 365 ASN L 376 -1 N GLU L 374 O GLU L 381 SHEET 6 LA 6 ARG L 322 SER L 330 -1 N PHE L 329 O HIS L 369 SHEET 1 LB 6 ASN L 75 SER L 79 0 SHEET 2 LB 6 ASN L 418 VAL L 426 -1 N ARG L 425 O ILE L 76 SHEET 3 LB 6 PHE L 408 VAL L 415 -1 N GLU L 414 O THR L 419 SHEET 4 LB 6 ILE L 279 PRO L 286 -1 N ILE L 284 O LEU L 409 SHEET 5 LB 6 THR L 267 PHE L 274 -1 N LEU L 272 O MET L 281 SHEET 6 LB 6 ARG L 259 VAL L 263 -1 N ARG L 261 O VAL L 269 SHEET 1 LC 3 THR L 234 LYS L 241 0 SHEET 2 LC 3 GLY L 244 GLU L 255 -1 N MET L 251 O ARG L 235 SHEET 3 LC 3 LEU L 316 ARG L 322 -1 N ARG L 322 O SER L 250 SSBOND 1 CYS I 8 CYS I 128 1555 1555 2.03 SSBOND 2 CYS I 21 CYS I 95 1555 1555 2.03 SSBOND 3 CYS I 247 CYS I 430 1555 1555 2.03 SSBOND 4 CYS L 8 CYS L 128 1555 1555 2.60 SSBOND 5 CYS L 21 CYS L 95 1555 1555 2.52 SSBOND 6 CYS L 247 CYS L 430 1555 1555 2.58 LINK ND2 ASN I 155 C1 NAG I 501 1555 1555 1.43 LINK ND2 ASN L 155 C1 NAG L 501 1555 1555 1.43 LINK ND2 ASN L 192 C1 NAG L 502 1555 1555 1.45 LINK O4 Z9L A 1 C1 Z9K A 2 1555 1555 1.42 LINK O4 Z9K A 2 C1 GU6 A 3 1555 1555 1.44 LINK O4 GU6 A 3 C1 GU1 A 4 1555 1555 1.42 LINK O4 GU1 A 4 C1 Z9H A 5 1555 1555 1.43 LINK O4 Z9L B 1 C1 Z9K B 2 1555 1555 1.43 LINK O4 Z9K B 2 C1 GU6 B 3 1555 1555 1.43 LINK O4 GU6 B 3 C1 GU1 B 4 1555 1555 1.42 LINK O4 GU1 B 4 C1 Z9H B 5 1555 1555 1.42 CRYST1 70.440 86.970 97.220 90.00 108.88 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014196 0.000000 0.004855 0.00000 SCALE2 0.000000 0.011498 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010871 0.00000